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Introduction
Mitochondria are critical to normal cell 
and organ function; they play a key role 
in metabolic homeo  stasis, in part, because 
of their central role in energy production. 
They also play major roles in apoptosis, 
control of cytosolic Ca2+ (calcium ion) 
levels, lipid homeostasis, steroid synthesis, 
generation of Fe-S (iron–sulfur) centers, 
heme synthesis, innate immune response, 
and metabolic cell signaling (Cheng and 
Ristow 2013; Papadopoulos and Miller 
2012; Suen et al. 2008; Tait and Green 
2012; Zemirli and Arnoult 2012) (Figure 1). 
Thus, it is not surprising that mitochondrial 
dysfunction underlies many diseases (e.g., 
Leber hereditary optic neuropathy, Alpers’ 
syndrome) that are individually rare but 
collectively occur at a rate of roughly 1 in 
4,000 individuals. Mitochondrial dysfunc-
tion and altered organel  lar regulation are also 
associated with some more common diseases, 
including cancers, neuro  degenerative diseases, 
and type 2 diabetes (Fariss et al. 2005; 
Van Houten et al. 2006). 
Mitochondrial proteins and mitochondrial 
DNA (mtDNA) are vulnerable to damage by 
reactive oxygen species (ROS) because ROS 
are produced during normal energy produc-
tion by oxidative phosphorylation and ATP 
generation via the electron transport chain 
(ETC). Mitochondria are also susceptible to 
insult from multiple natural and synthetic 
compounds that exert their toxicity by 
a) altering mtDNA integrity, b) inhibiting 
complexes in the ETC, c) modifying 
membrane potential, d) affecting Ca2+ 
transport, and e) activating pro  apoptotic 
signaling (Meyer et al. 2013). Furthermore, 
gene–environment interactions are critical 
in these events: Exposures to chemicals that 
are otherwise innocuous may cause disease 
and death in people with mutations or gene 
variants that affect mitochondrial function 
(Guan 2011; Silva et al. 2008). The asso-
ciation of mitochondrial dysfunction with 
numerous chronic diseases may reflect, in part, 
the vulnerability of mitochondria to environ-
mental and exogenous insults. In support 
of the Tox21 high-throughput screening 
program [National Institutes of Health (NIH) 
2014b], Attene-Ramos et al. (2014) used a 
cell-based assay to identify 1,222 compounds 
(~ 15% of the total compounds tested) that 
reduced mitochondrial membrane potential. 
However, whether such compounds act in a 
direct or indirect manner on mitochondrial 
functions—and what the specific mitochon-
drial targets are for these stressors—remains 
unclear. A systems approach, which enables 
real-time integration of the role of mitochon-
drial function in multiple cellular sensing and 
Address correspondence to D.T. Shaughnessy, 
Division of Extramural Research and Training, 
NIEHS, MD K3-12, P.O. Box 12233, Research 
Triangle Park, NC 27709 USA. Telephone: (919) 
541-2506. E-mail: shaughn1@niehs.nih.gov
We thank M. Longley and S. Nadadur for their 
review of this manuscript, and S. Edelstein for 
graphic design. 
R.W.S. is a scientific consultant for Trevigen Inc. 
(Gaithersburg, MD). The authors declare they have 
no actual or potential competing financial interests.
Received: 13 March 2014; Accepted: 14 August 
2014; Advance Publication: 15 August 2014; Final 
Publication: 1 December 2014.
Mitochondria, Energetics, Epigenetics, and Cellular Responses to Stress
Daniel T. Shaughnessy,1 Kimberly McAllister,1 Leroy Worth,1 Astrid C. Haugen,1 Joel N. Meyer,2 
Frederick E. Domann,3 Bennett Van Houten,4 Raul Mostoslavsky,5 Scott J. Bultman,6 Andrea A. Baccarelli,7 
Thomas J. Begley,8 Robert W. Sobol,4,9 Matthew D. Hirschey,10 Trey Ideker,11,12 Janine H. Santos,13 
William C. Copeland,14 Raymond R. Tice,15 David M. Balshaw,1 and Frederick L. Tyson1
1Division of Extramural Research and Training, National Institute of Environmental Health Sciences (NIEHS), National Institutes of 
Health (NIH), Department of Health and Human Services (DHHS), Research Triangle Park, North Carolina, USA; 2Nicholas School of the 
Environment, Duke University, Durham, North Carolina, USA; 3Free Radical and Radiation Biology Program, Department of Radiation 
Oncology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA; 4University of Pittsburgh Cancer Institute, Hillman 
Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; 5Massachusetts General Hospital Cancer Center, Harvard 
Medical School, Boston, Massachusetts, USA; 6Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, 
North Carolina, USA; 7Laboratory of Environmental Epigenetics, Exposure Epidemiology and Risk Program, Harvard School of Public 
Health, Boston, Massachusetts, USA; 8SUNY College of Nanoscale Science and Engineering, Albany, New York, USA; 9Department of 
Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA; 10Duke University 
Medical Center, Durham, North Carolina, USA; 11Department of Medicine, and 12Department of Bioengineering, University of California 
San Diego, La Jolla, California, USA; 13Laboratory of Molecular Carcinogenesis, and 14Laboratory of Molecular Genetics, NIEHS, NIH, 
DHHS, Research Triangle Park, North Carolina, USA; 15Biomolecular Screening Branch, Division of the National Toxicology Program, 
NIEHS, NIH, DHHS, Research Triangle Park, North Carolina, USA 
Background: Cells respond to environmental stressors through several key pathways, including 
response to reactive oxygen species (ROS), nutrient and ATP sensing, DNA damage response (DDR), 
and epigenetic alterations. Mitochondria play a central role in these pathways not only through 
energetics and ATP production but also through metabolites generated in the tri  carboxylic acid 
cycle, as well as mitochondria–nuclear signaling related to mitochondria morphology, bio  genesis, 
fission/fusion, mitophagy, apoptosis, and epigenetic regulation. 
oBjectives: We investigated the concept of bidirectional interactions between mitochondria and 
cellular pathways in response to environmental stress with a focus on epigenetic regulation, and 
we examined DNA repair and DDR pathways as examples of biological processes that respond to 
exogenous insults through changes in homeostasis and altered mitochondrial function.
Methods: The National Institute of Environmental Health Sciences sponsored the Workshop on 
Mitochondria, Energetics, Epigenetics, Environment, and DNA Damage Response on 25–26 March 
2013. Here, we summarize key points and ideas emerging from this meeting. 
discussion: A more comprehensive understanding of signaling mechanisms (cross-talk) between the 
mitochondria and nucleus is central to elucidating the integration of mitochondrial functions with 
other cellular response pathways in modulating the effects of environmental agents. Recent studies 
have highlighted the importance of mitochondrial functions in epigenetic regulation and DDR with 
environmental stress. Development and application of novel technologies, enhanced experimental 
models, and a systems-type research approach will help to discern how environ  mentally induced 
mitochondrial dysfunction affects key mechanistic pathways.
conclusions: Understanding mitochondria–cell signaling will provide insight into individual 
responses to environmental hazards, improving prediction of hazard and susceptibility to 
environmental stressors.
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response pathways—including redox signaling, 
nutrient sensing, and multiple biosynthetic 
pathways—would enhance our under-
standing of exposure-induced mitochondrial 
dysfunction. Recent studies have illustrated 
the extent to which mitochondria are inte-
grated into cellular responses under changing 
environments (Meyer et al. 2013).
In this review, we discuss the concept of 
cross-talk between mitochondria and other 
cellular pathways in response to environ  mental 
stress. A more comprehensive understanding of 
cellular stressors on acute responses and disease 
pathologies based on the role of energetics and 
other mitochondrial functions interacting with 
key pathways will be critical to elucidating 
their contribution to health outcomes.
Methods
The National Institute of Environmental 
Health Sciences (NIEHS) sponsored the 
Workshop on Mitochondria, Energetics, 
Epigenetics, Environment, and DNA 
Damage Response on 25–26 March 2013. 
A major goal of the meeting was to discuss 
mitochondria–cell signaling in different cell 
types and organisms, with changing stress 
conditions, in order to understand the 
relation  ship between mitochondrial function, 
cellular homeostasis, and disease. A series of 
roundtable discussions resulted in a set of 
recommendations and research opportuni-
ties to promote this field of research. In this 
review, we further consider the state of the 
science discussed at the workshop.
Discussion
Mitochondrial function and epigenetics. 
Mitochondria provide key metabolites 
[including but not limited to β-nicotinamide 
adenine dinucleotide (NAD+), ATP, 
α-ketoglutarate (α-KG; also called 2-oxoglu-
tarate, 2-OG), and acetyl coenzyme A 
(acetyl CoA)] that are co-substrates required 
for numerous transcriptional and epi  genetic 
processes (e.g., chromatin remodeling, histone 
modifications, nucleo  some positioning) (Cyr 
and Domann 2011; Donohoe and Bultman 
2012; Martinez-Pastor et al. 2013) (Figure 2). 
Although it is anticipated that mitochondria 
may play a critical role in regulating gene 
expression, data demonstrating that mito-
chondrial metabolites are rate limiting for 
Figure 1. Mitochondria–nuclear signaling. Abbreviations: ACL, ATP citrate lyase; AMPK, AMP-activated protein kinase; Acetyl CoA, acetyl coenzyme A; ERK, 
extracellular signal-regulated kinase; HATs, histone acetyltransferases; HDACs, histone deacetylases; Hif1-α, hypoxia inducible factor 1 alpha; MAT, methionine 
adenosyl transferase;  MAVS; mitochondrial antiviral signaling protein; Met, methionine; mTOR, mechanistic target of rapamycin; NFκB, nuclear factor kappa B; 
PARP, poly(ADP-ribose) polymerase 1; SAM, S-adenosylmethionine; TCA, tri  carboxylic acid cycle. Mitochondrial functions include cellular energy production via 
ATP generation, Ca2+ metabolism, synthesis of macro  molecules, generation of metabolites for epigenetic regulation, and innate immune response to viral infection 
through MAVS. Nuclear–mitochondria signaling is mediated by numerous pathways, including epigenetic regulation/chromatin modification via sirtuins (e.g., SIRT1 
and SIRT6), HDACs, and HATs, which require acetyl CoA from the TCA cycle; nutrient sensing through the AMPK and mTOR signaling pathways; DDR mediated by 
PARP, ATM, SIRT1, and AMPK; and redox signaling through overlapping pathways mediated by ATM/Chk2, p53, Hif1-α, ERK, and NFκB. 
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epigenetic modifiers are still lacking (Cai et al. 
2011; Lu and Thompson 2012). Nevertheless, 
increasing evidence points to the role of mito-
chondria in modulating the epigenome. For 
instance, neomorphic gain of function muta-
tions in isocitrate dehydrogenase (IDH1 or 
IDH2) results in the conversion of α-KG to 
2-hydroxyglutarate, which can inhibit DNA 
demethylases and alter gene expression 
patterns (Schulze and Harris 2012). In cases 
of acute myeloid leukemia and glioblastoma, 
the IDH1/2 mutation results in the forma-
tion of 2-OH-glutarate, which is a competi-
tive inhibitor of α-KG–dependent processes, 
especially demethylation of histones (Turcan 
et al. 2012; Ward et al. 2012). Histone acetyla-
tion has multiple roles in transcriptional 
regulation, including the provision of binding 
sites for proteins containing bromo  domains, 
alteration of chromatin sub  nuclear localiza-
tion and structure, and neutralization of 
histone positive charges (Wellen et al. 2009). 
Ladurner (2009) pointed out that Wellen 
et al. (2009) showed how mitochondrially 
generated citrate can serve as a substrate for 
the production of nuclear acetyl Co-A. A few 
studies have demonstrated the requirement 
of a pool of acetyl Co-A for global histone 
acetyla  tion by histone acetyl  transferases (Cai 
et al. 2011; Takahashi et al. 2006). In addition 
to the direct provision of substrates, mito-
chondria can influence epigenetic signaling 
indirectly through ROS generation [e.g., 
hydrogen peroxide (H2O2)] (Desouki et al. 
2005; Smiraglia et al. 2008). Epigenetic altera-
tions in response to ROS may in turn result 
in altered expression of genes that regulate 
mitochondrial metabolism. In addition to 
endogenous metabo  lite levels, metals and other 
environmental pollutants have been shown 
to alter epigenetic patterns, including global 
DNA methylation and histone modifications 
in vitro and in vivo (Byun et al. 2013; Hou 
et al. 2012).
Metabolic epigenetics refers to nuclear 
alterations of chromatin and other factors 
that regulate gene expression resulting from 
changes in mitochondrial energetics and 
metabolism. The resulting metabolites, in 
turn, mediate gene expression changes that 
control cellular processes, including energy 
homeostasis (Wallace and Fan 2010). Thus, 
energy status and metabolism are able to 
modulate epi  genetic programming via chro-
matin structural changes and dynamics, 
DNA methylation, histone modifications, 
and non  coding RNA expression. Epigenetic 
modifiers include DNA methyltransferases, 
histone acetyl  transferases, histone deacetylases, 
sirtuins (SIRTs), histone lysine demethylases, 
poly(ADP-ribose) polymerases, and others that 
work coordinately to regulate gene expression. 
Multiple changes in cellular energetics and 
epigenetic processes that are mediated by 
factors including SIRTs and chromatin 
states (Figure 2) have been observed in inves-
tigations of complex diseases. For instance, 
reprogramming of energy metabolism has 
been identified as an emerging hallmark of 
cancer (Hanahan and Weinberg 2011; 
Nakajima and Van Houten 2013). Alterations 
that promote or enable a shift in mitochon-
drial metabolism toward aerobic glycolysis 
may pre  dispose cells to a carcinogenic-type 
phenotype (Vander Heiden et al. 2009). For 
example, SIRT6 acts as a nutrient sensor by 
linking epi  genetic gene silencing and cellular 
energetics in maintaining genome stability 
and tumor suppression. A recent study indi-
cated that SIRT6 acts specifically in these 
processes as a co  repressor of hypoxia-inducible 
factor 1-alpha (HIF1α) and MYC targets 
via both H3K9 and H3K56 deacetyla  tion 
(Sebastian et al. 2012). This implicates SIRT6 
as a tumor suppressor through its ability to 
down-regulate aerobic glycolysis in tumor 
cells (Ho et al. 2012). An emerging concept 
is that tumor cells are metabolically flexible 
and hypoxic regions of the tumor may display 
increased glycolysis and glucose utilization, 
whereas other well-vascularized regions of the 
tumor may show high levels of oxidative phos-
phorylation using different carbon sources (Ho 
et al. 2012; Nakajima and Van Houten 2013). 
For example, ovarian and prostate cancers 
show high levels of fatty acid beta-oxidation 
(Nieman et al. 2013).
Another central function of mitochondria 
is ROS signaling and sensing. Indeed, mito-
chondria operate as redox sensors that can 
alter energy states in response to the chemical 
environment of the cell and relative levels 
of endogenous metabolites such as iron(II), 
succinate, and ascorbate, as well as various 
forms of ROS. However, how ROS sensing 
is mediated by mitochondrial function 
and how different ROS sensing pathways 
overlap are not well understood. Certainly, 
Figure 2. Tri  carboxylic acid (TCA) cycle metabolites. Abbreviations: Acetyl CoA, acetyl coenzyme A; ACL, 
ATP citrate lyase; HAT, histone acetyltransferase; HDAC, histone deacetylase; PARP, poly(ADP-ribose) 
polymerase 1. Metabolites formed in the TCA cycle are important substrates for proteins involved 
in epigenetic regulation and DDR. Citrate, converted to Acetyl CoA by ATP citrate lyase (ACL) in the 
cytoplasm and nucleus, is required for histone acetylation by HATs. NAD+ is required for SIRT1 activity 
and PARP activation in DDR and apoptosis pathways, and α-ketoglutarate is a cofactor for the TET family 
of dioxygenases that convert 5-methylcytosine to 5-hydroxymethylcytosine, which can be replaced by 
unmethylated cytosine via DNA repair activities (deamination and BER). 
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changes in redox states can influence DNA 
methyla  tion (Hitchler and Domann 2009) 
because the oxidation of 5-methylcyto-
sine to 5-hydroxy  methyl  cytosine in CpGs 
can perturb recognition by methyl-binding 
proteins and subsequently alter methylation 
patterns and epigenetic regulation (Hitchler 
and Domann 2012).
Dietary changes, including carbon sources, 
can also affect mitochondrial function and 
epigenetics (Zhang et al. 2012). Butyrate, 
for example, is a very short-chain fatty acid 
that has multiple roles in the cell and serves 
as a key energy metabolite, histone deacety-
lase inhibitor, and—via the generation of 
acetyl-CoA—as a histone acetyl  transferase 
activator (Andriamihaja et al. 2009; Donohoe 
and Bultman 2012). Butyrate is generated 
by micro  biota in the colon during the diges-
tion of dietary fiber (Leschelle et al. 2000). 
Donohoe et al. (2011) demonstrated that in 
colon cells, the microbiota is a key regulator 
of energetics because normal colono  cytes use 
bacterial butyrate as a primary aerobic energy 
substrate. Butyrate also inhibits cell prolifera-
tion in colon cancer cells and conversely 
stimulates growth in normal colon cells. These 
results suggest that normal cells and colon 
cancer cells utilize butyrate differently in a 
manner that affects epigenetic processes.
An additional epigenetic–mitochondrial 
interaction could be the alteration of mtDNA 
methylation by environmental stressors, 
although it is currently unclear whether 
mtDNA transcription is linked to altered 
mtDNA methylation in the same manner 
as is nuclear DNA (nDNA) methylation. 
Furthermore, effects of exposures on putative 
mitochondrial epigenetic states will gener-
ally occur in the context of direct effects on 
both mitochondrial and nuclear epigenetics; 
these effects may or may not be mechanis-
tically linked. For example, what are the 
steps involved in response to air pollution? 
Is the mitochondrial response an early step 
in cellular reprogramming (e.g., an increase 
in mitochondrial content or biogenesis, 
followed by alterations in methylation of 
nuclear-encoded mitochondrial genes)? 
Recent human studies have demonstrated 
effects of air pollution exposure on mtDNA 
copy number, a marker that can be applied in 
large population studies and may reflect both 
mtDNA damage and dysfunction (Carugno 
et al. 2012; Hou et al. 2010, 2013; Janssen 
et al. 2012; Pavanello et al. 2013). There is 
growing evidence suggesting that air pollution 
exposure modifies methylation not only in 
the nDNA but also in the mtDNA (Baccarelli 
et al. 2009). Although this finding might help 
to identify individuals at higher risk of air 
pollution effects, including acute and long-
term cardio  respiratory disease, lung cancer, 
and neurological effects, there are conflicting 
reports in the literature regarding the function 
of mtDNA methylation (Dzitoyeva et al. 
2012; Hong et al. 2013; Iacobazzi et al. 
2013). A fundamental question is whether 
cytosine methylation takes place in mtDNA, 
particularly in sequences that are rich in CpG 
dinucleotides. Intriguingly, recent evidence 
appears to suggest that methylation can 
occur in cytosines both in a CpG context 
and in cytosines that are not in CpG sites. 
Specifically, increased cytosine methylation 
has been observed in promoter regions of 
the mitochondria heavy strand located at 
the 5´-end of the D-loop (involved in DNA 
synthesis), suggesting a role in regulating 
mtDNA replication. Moreover, the observa-
tion of 5-hydroxymethylcytosine in mtDNA 
provides additional evidence that mtDNA 
may be epigenetically regulated. That this 
base has been established without the action 
of TET dioxygenases, which do not contain 
a mitochondrial targeting sequence, suggests 
other modes for demethylation and ulti-
mately metabolic reprogramming that could 
be mediated via cross-talk with the nucleus 
(Bellizzi et al. 2013; Shock et al. 2011).
Mitochondria and DNA damage response. 
Mitochondrial functions are also tightly 
integrated with cellular responses to damage 
in both mtDNA and nDNA. Given the 
significant generation of ROS during normal 
mitochondrial functions, it is not surprising 
that base excision repair (BER), which repairs 
most oxidative DNA damage, is a critical 
DNA repair pathway in the maintenance 
of mtDNA integrity (Mandal et al. 2012; 
Maynard et al. 2010). Other DNA repair 
pathways that protect the nuclear genome—
including mismatch repair as well as repair of 
DNA double-strand breaks through homolo-
gous recombination or non  homologous end 
joining—may be active in mitochondria, but 
the specific roles for these pathways, or the 
proteins involved in maintaining mtDNA 
stability, are not clear (Alexeyev et al. 2013; 
Kazak et al. 2012). Nucleotide excision repair, 
which repairs damage resulting from many 
common environmental geno  toxicants (Basu 
and Blair 2011) including polycyclic aromatic 
hydrocarbons, mycotoxins, and ultraviolet 
radiation, is not present in mitochon-
dria (Kazak et al. 2012). Recent research is 
improving our understanding of the relation-
ship between nDNA and mtDNA repair 
pathways, the effects of persistent mtDNA 
damage, and the energetic requirements for 
both nDNA and mtDNA DDR pathways.
Repair of oxidative and alkylation DNA 
damage in mitochondria through BER occurs 
in a manner similar to that of nDNA with 
several modifications: Gap filling in both 
short- and long-patch repair is carried out by 
polymerase gamma and its accessory subunits, 
DNA ligase III and EXOG (which carries out 
5´ to 3´ exonuclease activity in long-patch 
BER) (Cymerman et al. 2008). Depletion of 
EXOG in human cell lines results in persis-
tent single-strand breaks in mtDNA, increased 
mitochondrial dysfunction, and increased 
apoptosis (Tann et al. 2011). Similarly, DNA 
ligase III activity has been shown to be critical 
for mtDNA repair and cell survival (Simsek 
et al. 2011). In general, loss of BER activities, 
including EXOG or DNA ligase III, would be 
expected to cause single-strand breaks, leading 
to a decrease in mitochondrial transcription 
and subsequent defects in the ETC, and ROS 
production, ultimately leading to cell death 
or necrosis (Sharma et al. 2014). In support 
of this, intrinsic mtDNA repair defects are 
observed in the disease ataxia telangiectasia 
in which DNA ligase III levels are signifi-
cantly reduced. This decrease in ligase III 
leads to slower kinetics of mtDNA repair, loss 
of mtDNA integrity, and ultimately mito-
chondrial dysfunction (Sharma et al. 2014).
Recent studies suggest that specific 
types of DNA damage have varying effects 
on mitochondrial function and cell survival. 
Furda (et al. 2012) demonstrated that given 
similar levels of mtDNA lesions in mouse 
embryonic fibroblasts, treatment with the 
alkylating agent methyl methane  sulfonate 
had little effect on mitochondrial function, 
whereas H2O2-treated cells exhibited signifi-
cant mtDNA loss, disruption of the ETC 
complex Vα subunit and complex 1 levels, 
and a decline in oxidative phosphorylation. 
Other studies have reported that DNA lesions 
generated from ultraviolet C radiation–treated 
Caenorhabditis elegans were not repaired but 
also did not persist indefinitely in mtDNA 
(Bess et al. 2012). The slow disappearance of 
these lesions was abrogated in nematodes in 
which expression of mitochondrial fusion, 
fission, and autophagy proteins was knocked 
down by RNAi (RNA interference) (Bess et al. 
2012). Furthermore, these lesions resulted in 
mitochondrial dysfunction (Leung et al. 2013) 
that was exacerbated in the context of defi-
ciencies in some mitochondrial fusion, fission, 
and autophagy proteins (Bess et al. 2012, 
2013). Thus, other mitochondrial quality-
control mechanisms, including fission, fusion, 
and mitophagy, are responsible for protecting 
mitochondrial function and tolerance of 
mtDNA lesions (Figge et al. 2012).
Increasingly, proteins typically thought 
of as mitochondrial have been found to have 
critical extra-mitochondrial “moonlighting” 
roles, and, conversely, proteins typically 
thought of as extra-mitochondrial have 
demonstrated mitochondrial effects. Qian 
et al. (2012) reported that inhibition of the 
mitochondria fission protein Drp1 causes cell 
cycle disruption, with G2 arrest, abnormal 
DNA content, aneuploidy, and other chro-
mosome abnormalities in human cell lines. Mitochondria and stress response
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Effects on cell cycle progression were indepen-
dent of mitochondrial energy metabolism and 
ROS generation. The under  lying mechanism 
for Drp1 deficiency leading to G2/M arrest 
and aneuploidy is not yet known. However, 
it may be mediated by mitochondrial hyper-
fusion leading to aberrant cyclin E expres-
sion during G2 and replication stress that 
induces the G2/M checkpoint. Conversely, 
several studies have shown that the DDR 
protein ATM (ataxia-telangiectasia mutated) 
also functions in redox sensing, insulin 
signaling, and cellular energy balance through 
the AMPK (AMP-activated protein kinase) 
pathway (Ditch and Paull 2012), and appears 
to play an important role in mitochondrial 
homeostasis (Valentin-Vega and Kastan 
2012). Thymocytes from Atm-null mice show 
altered mitochondrial morphology, elevated 
ROS levels, and decreased ETC activity and 
ATP production. Loss of ATM also leads to 
increased mitochondrial mass and oxygen 
consumption, suggesting impairment of 
mitophagy (Valentin-Vega et al. 2012). The 
recent observations that DNA ligase III levels 
are decreased in the absence of ATM may also 
explain these results (Sharma et al. 2014).
DDR pathways are highly energy depen-
dent, with requirements for ATP and NAD+ 
during DNA damage sensing and repair 
activities. For example, poly(ADP-ribose) 
polymerase 1 (PARP1) plays a crucial role in 
multiple repair pathways, including BER, in 
sensing damage and initiating and completing 
repair of DNA lesions and DNA strand breaks. 
PARP1 activation requires NAD+ and serves 
to recruit repair activities to the damaged site. 
Incomplete repair (e.g., BER failure), possibly 
from PARP1 hyper  activation and cellular 
energy depletion, leads to cell death (Jelezcova 
et al. 2010; Tang et al. 2010). How cellular 
processes, including DDR, are regulated 
through PARP1 activation and alterations 
in NAD+ metabolites is not understood, but 
this is another example of critical interactions 
between mitochondrial function and energetics 
and cellular responses to stress.
Cells may also respond to extensive DNA 
damage through apoptosis, and mitochondria 
play a key role in this pathway through activa-
tion of BCL-2-associated X protein (BAX) or 
BCL-2 antagonist/killer (BAK) in response 
to pro  apoptotic signals including DNA 
damage. Activation of BAX and BAK leads 
to mitochondrial outer membrane permea-
bilization and release of cytochrome c, which 
binds and activates pro  apoptotic factors that 
include APAF1, caspase 3, and caspase 7 (Tait 
and Green 2010). Autophagy, which acts in 
cellular detoxification, energy production, and 
anabolic processes under conditions of cellular 
stress, is also regulated by mitochondria. For 
example, under nutrient starvation and low 
ATP conditions, AMPK phosphorylates 
a number of autophagy-related proteins 
including ULK1 and the mTORC1 regulators, 
TSC2 and RAPTOR (Tait and Green 2012).
Recommendations and 
Research Opportunities
The Mitochondria, Energetics, Epigenetics, 
Environment, and DNA Damage Response 
workshop defined key gaps in research and 
understanding regarding cross-talk between the 
nucleus and mitochondria. Research exploring 
the signaling associated with the DDR, 
epigenetics, and mitochondrial dynamics 
and energetics forms a basis for exploring the 
cross-talk between these pathways in environ-
mentally mediated disease. In addition, key 
recommendations were identified for resources, 
infrastructure, and technologies needed to 
move this field forward. In particular, there 
is a need to move toward in vivo, real-time 
measures of metabolites with increased resolu-
tion as key indicators for unraveling the cross-
talk between the nucleus and mitochondria. 
Some of the major recommendations from this 
workshop are presented below.
Metabolomics and flux technologies. The 
relationship between mitochondrial dynamics 
and energy metabolism is still poorly under-
stood, and predicted paths from metabolomics 
are underdeveloped. Identifying the role of 
small molecules in mediating the cross-talk 
is approachable using today’s metabolomics 
technologies, including improvements to 
metabolomics technologies and enhanced 
training supported through the NIH Common 
Fund Metabolomics Program (NIH 2014a). 
However, there is a need for focused develop-
ment to enable further studies. One key area is 
in improved flux analysis, which allows for the 
investigation of biological reactions at steady 
state through monitoring stable isotope levels 
in both in vitro and in vivo studies (Basu and 
Blair 2011; Gravel et al. 2014; Maher et al. 
2012; Sauer 2006; Zamboni 2011). This 
technology needs to be developed to the 
level of other “omics” technologies, particu-
larly by coupling it with transcriptomics and 
epigenomics data integration.
Further advances in technology will also 
be necessary to apply these technologies in 
high-throughput screening efforts. Improving 
three-dimensional imaging and new methods 
in sequencing mtDNA will be particularly 
important in this regard. For measuring mito-
chondrial function in intact cells and isolated 
mitochondria, the Seahorse Flux analyzer 
(Seahorse Biosciences) has revolutionized mito-
chondrial studies in terms of enabling high-
throughput measurement of mitochondrial 
metabolism (Kembro et al. 2013; Qian and 
Van Houten 2010). However, other studies 
are needed to link these end points with 
changes in the mitochondrial proteome or 
metabolite profiles. Affinity purification mass 
spectrometry is a technology that can detect 
the effects of exposure on protein interactions 
in human cell culture. Several studies have 
employed magnetic resonance spectroscopy 
to monitor changes in mitochondrial metabo-
lism in human patients with Friedreich ataxia 
(Nachbauer et al. 2013) and in controlled 
studies of the effects of exercise on muscle 
oxidative capacity in healthy subjects (Layec 
et al. 2013). For high-throughput screening, 
the Tox21 program is currently using a mito-
chondria membrane potential assay to screen 
large numbers of environmental compounds 
and drugs for effects on mitochondrial 
function (Attene-Ramos et al. 2014). As such 
intensive screening efforts continue, there is 
increasing need for enhanced support for infra-
structure to allow storage of chemical-response 
data from high-throughput screening efforts, as 
well as from other assays, to be appropriately 
cataloged and published as a public resource.
Another fundamental need is the ability 
to precisely track free radicals and distinguish 
different types of ROS via their source and 
mode of generation in the cell. Oxidative 
damage is 5–10 times higher in mtDNA than 
in nDNA, and mitochondria are directly 
exposed to endogenous ROS. Yet it is not 
known how much mitochondrially gener-
ated H2O2 reaches the nucleus. The develop-
ment of fluorescent probes will enable studies 
that will more accurately measure localized 
ROS and how different perturbations affect 
ROS. This will require collaborative, multi-
disciplinary expertise between chemists and 
cellular and molecular biologists. Success in 
applying these probes will also require the 
evolution of technologies for the imaging of 
metabolites in cells to enable studies of the 
sub  cellular localization of signaling activities. 
Having such tools to track small molecule and 
free radical diffusion will enable studies that 
can better address low-dose toxicant exposures 
that are relevant to disease pathogenesis.
Human populations systems and experi-
mental models. The Mitochondria, Energetics, 
Epigenetics, Environment, and DNA Damage 
Response workshop highlighted a variety 
of resources available in human popula-
tion studies and cell systems that might be 
particularly useful for understanding cross-talk 
between the mitochondria and nucleus, and 
between diverse biological pathways. Research 
involving childhood cancer survivors, many of 
whom show adverse health outcomes later in 
life (Hudson et al. 2013); progeria patients; 
and HIV patients treated with nucleoside 
analogs including AZT (azidothymidine) 
might offer opportunities to study the roles 
for altered mitochondrial function and ener-
getics on other cellular pathways because many 
chemo  therapeutics and nucleoside analogs 
cause mitochondrial damage (Cossarizza and 
Moyle 2004; Poirier et al. 2003). In vitro Shaughnessy et al.
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assays using human differentiated induced 
pluripotent stem (iPS) cells from patients with 
inherited mitochondrial defects and unaffected 
individuals could be used to evaluate differ-
ential sensitivity to mitochondrial toxicants 
and better understand tissue and cell specificity 
and tissue-specific thresholds for mitochondrial 
functions involved in highly hetero  geneous 
mtDNA diseases (Fujikura et al. 2012; 
Hamalainen et al. 2013). In particular, repro-
gramming somatic cells from patients with 
mtDNA dis  orders can generate pluri  potent 
stem cells with varying degrees of hetero  plasmy 
and allows the creation of patient-specific 
pluri  potent cells that retain the functional 
charac  teristics of donor cells, including disease-
associated mtDNA (Cherry et al. 2013). 
Studying repair capacity for mitochondrial 
genetic variants in human populations is also 
helpful for understanding the genetic suscep-
tibility under  lying environmental exposures 
in diverse health outcomes resulting from 
mitochondrial dysfunction. 
In some cases, research using model 
organisms has distinct advantages compared 
with human cell culture systems or other 
human population-based approaches. For 
example, yeast is an ideal model organism 
for under  standing some human mitochon-
drial myopathies because of the advantages 
of monitoring fermentative growth in the 
case of respiratory-deficient mutants. Another 
strength of the yeast model is the ability 
to introduce multiple homo  plasmic mito-
chondrial mutations for studying diseases 
such as Leber hereditary optic neuropathy, 
where multiple mitochondrial mutations 
are responsible for the pathologies (Meunier 
et al. 2013). Drosophila melanogaster has 
been useful in understanding the dysfunc-
tion of mitochondrial dynamics (especially 
mitochondria-shaping proteins) and its role 
in disrupting mitochondrial bioenergetics, 
which is implicated in neuro  degenerative 
diseases (Debattisti and Scorrano 2013). 
Zebrafish models have been used to examine 
complex I and II deficiencies in both 
primary mitochondrial diseases, such as 
Charcot-Marie-Tooth, and in other neuro-
degenerative diseases associated with complex 
I or II deficiencies, such as Parkinson’s disease 
and Huntington’s disease. In addition, 
the zebrafish has emerged as a significant 
model for understanding the bio  energetics 
of environ  mentally relevant aquatic pollut-
ants and in applications related to in vivo 
toxicity screening of chemicals affecting 
mitochondrial function (Bourdineaud et al. 
2013; Pinho et al. 2013). The development 
of powerful new approaches in population-
based mouse resources will also contribute to 
a greater under  standing of the role of suscep-
tibility and resistance to chemically induced 
mitochondrial dysfunction related to human 
disease (Flint and Eskin 2012). In vitro assays 
using embryonic stem/iPS cells from the 
Collaborative Cross/Diversity Outbred mouse 
models could identify genetic factors in 
differen  tial sensitivity to toxicants, which can 
then be followed by in vivo studies to demon-
strate functional relevance. Although cellular 
and genetic develop  mental processes asso-
ciated with many mitochondrial functions 
are highly conserved between these model 
organisms and humans, cross-species extrapo-
lation should focus on conserved pathways 
rather than on disease phenotypes to ensure 
that valid conclusions are drawn.
Systems integration and focused investiga-
tions on cross-talk in environmental health. 
As discussed above, cross-talk between the 
nucleus and mitochondria occurs partly via 
epigenetic pathways with many potential 
mitochondrial/epigenetic interactions, such 
as nDNA methylation effects on transcrip-
tion of mRNA for mitochondrial proteins or 
the effects of mtDNA depletion on altered 
nDNA methylation. However, the many 
ways in which mitochondrial damage and 
dysfunction may be related to mitochondrial 
epigenetics and environmental disease are still 
poorly understood. 
Additional research is needed in several 
important areas. Although nuclear CpG 
methylation receives substantial attention, 
methylation of mtDNA and its functional 
consequences are less well known. Unlike 
nDNA, mtDNA CpG sites are abundant, 
and a link between cytosine methylation 
and transcriptional alterations has not been 
established. Nevertheless, mtDNA methyla-
tion may represent an environmental target, 
with some mitochondrial toxicants potentially 
affecting cytosine methylation or mtDNA 
alkylation in general. Some evidence also 
suggests that mitochondrial DNA copy 
number may be an important environmental 
biosensor. Therefore, we need to understand 
the relevance of mtDNA copy numbers and 
mtDNA methylation to exposure-related 
human disease and whether relationships may 
exist with mtDNA haplogroups. There is some 
evidence that haplotypes of the mitochon-
drial genome affect stem cell differentiation 
and expression of genes involved in pluri-
potency, differentiation, and mitochondrial 
energy metabolism (Wittkopp et al. 2013). 
Protein acetylation is also an important regu-
latory mechanism, and diseases associated 
with mitochondrial dysfunction may also be 
related to protein acetylation, including type 2 
diabetes, obesity, and cancer (Finkel et al. 
2009; Hirschey et al. 2011; Sebastian et al. 
2012). Protein acetyla  tion is also common 
in the mitochondria, possibly affecting two-
thirds of mitochondrial proteins, including 
many involved in energy-producing pathways, 
but the impact of such events are poorly 
understood. Clearly these data indicate a rich 
area for discovery.
A better understanding of how critical 
windows of susceptibility and developmental 
timing affect nucleus/mitochondria cross-talk 
is also needed. In general, the abundance of 
mtDNA in cells can be protective against 
damage, but this varies by cell type and 
develop  mental stage, which creates possible 
windows of vulnerability. Early develop-
mental stages typically have lower mtDNA 
copy number, a phenomenon especially well-
documented in the context of primordial 
germ cells (Carling et al. 2011; Jansen and 
de Boer 1998; Shoubridge and Wai 2007). 
Furthermore, periods of global demethyla-
tion during develop  mental windows may 
be particularly sensitive periods for effects 
of environmental stressors. Mapping the 
mitochondrial proteome, post-translational 
modifications (including phosphorylation, 
acetylation, sumoylation, parylation) in 
different cell types and stages of development, 
and combining mitochondrial proteome 
analysis with imaging will be informative, 
especially given the wide variability in mito-
chondrial form and function in different 
tissues and develop  mental stages (Johnson 
et al. 2007; Vafai and Mootha 2012). A 
better understanding of the reprogramming 
of mitochondrial genes during development 
might be gained through studying iPS cells 
and differentiated cells of interest. Participants 
of the Mitochondria, Energetics, Epigenetics, 
Environment, and DNA Damage Response 
workshop also emphasized the need for longi-
tudinal prospective studies linking past expo-
sures to mtDNA markers and phenotypes to 
better understand windows of susceptibility.
Recent studies have highlighted the overlap 
between DDR processes in the mitochondria 
and nucleus. In general, the presence of fewer 
DNA repair pathways in mitochondria confers 
greater vulnerability to damage, but we need 
to better understand DNA damage from 
environ  mental exposures in terms of effects 
on mitochondria versus only the nucleus. At 
present, it is difficult to determine when an 
exposure is a primary mitochondrial response 
(or a mitochondrial toxicant) rather than a 
mitochondrial response that occurs second-
arily after a toxicant affects another sub  cellular 
target. There may be patterns of “omics” 
data (e.g., gene expression, genetic or protein 
interactions) that are indicative of distinct 
DNA repair mechanisms and could thus serve 
as a biomarker for particular types of DNA 
damage. In this regard, differential genetic 
networks are a powerful new tool for mapping 
the altered structure, as well as the function, 
of biological networks in response to environ-
mental stresses (Ideker and Krogan 2012). In 
yeast, large networks of genetic inter  actions 
have been shown to be substantially rewired Mitochondria and stress response
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by different types (Guenole et al. 2013) and 
levels of DNA damage (Srivas et al. 2013), 
suggesting that the interaction pattern itself 
is a sensitive measure of how DNA damage 
is being handled and by what sub  pathways. 
It is likely that further insight into the cross-
talk and signaling mechanisms between the 
mitochondria and the nucleus, as well as the 
interplay between mitochondria and toxicants, 
will warrant such a systems biology approach. 
Cross-disciplinary efforts between system 
biologists, biochemists, and basic molecular 
biologists will be needed to develop the tools 
and approaches needed to detect alterations 
in mitochondrial-cellular signaling under 
changing stress conditions. In addition, better 
systems analysis tools are needed, such as the 
Gene Set Enrichment Analysis tools developed 
by the Broad Institute (Mootha et al. 2003; 
Subramanian et al. 2005).
Conclusions
Development and application of novel 
technologies, including new reagents for 
tracking the production and distribution of 
specific ROS, expanded fluxomics analysis, 
new proteomics and metabolomic approaches, 
and application of tools for studying DNA 
methylation and chromatin remodeling, will 
enable systems-based approaches to investi-
gate how environmentally induced mitochon-
drial dysfunction affects other key pathways, 
including epi  genetic regulation and DDR, and 
conversely, how alterations in these pathways 
affect mitochondrial function. A more 
comprehensive understanding of the cross-
talk between mitochondria and other cellular 
response pathways will significantly improve 
our understanding of how cells sense and 
respond to environmental stress and will help 
to form a more solid basis for developing early 
biomarkers of environmentally related diseases.
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